Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 9, 2024, Avalon BioVentures SPV I, L.P.'s relationship to Janux Therapeutics, Inc. (JANX) is TenPercentOwner, and currently has 9,182 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other JANX insiders.

Data Source: SEC.
Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions of JANX Common Stock
Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 10, 2024 Sell -- (Common Stock) 2182 42.33 7000
Sep 10, 2024 M -- (Common Stock) 994 17 8077
Sep 10, 2024 M -- (Common Stock) 414 10.73 8491
Sep 10, 2024 M -- (Common Stock) 414 13.22 8905
Sep 10, 2024 M -- (Common Stock) 277 39.8 9182
Sep 7, 2024 Sell -- (Common Stock) 20991 42 612682
Sep 7, 2024 Sell -- (Common Stock) 108365 42 3162851
Sep 7, 2024 Sell -- (Common Stock) 110644 42 3229374
Nov 14, 2023 P -- (Common Stock) 849854 5.87 849854